Mukka Proteins Faces Financial Struggles Amid Declining Sales and Investor Confidence

Mukka Proteins, a microcap player in the FMCG sector, has recently undergone an adjustment in evaluation, reflecting a revision in its score. This change is attributed to a shift in technical trends, which have transitioned from a mildly bearish stance to a bearish outlook.
In terms of key financial metrics, the company reported a significant decline in net sales for the latest quarter, with figures showing a drop of 32.1% compared to the previous four-quarter average. Profit Before Tax (PBT) also saw a notable decrease, falling by 101.8%, while Profit After Tax (PAT) experienced a substantial decline of 86.8%.

The company's Return on Capital Employed (ROCE) stands at 9.48%, indicating challenges in profitability relative to total capital. Additionally, Mukka Proteins has a high Debt to EBITDA ratio of 4.36 times, suggesting difficulties in servicing its debt obligations.

Institutional investor participation has also waned, with a decrease of 0.65% in their stake over the last quarter, now collectively holding 3.96% of the company. This trend, combined with the stock's performance, which has yielded a return of -41.42% over the past year, underscores the challenges Mukka Proteins faces in the current market environment.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.